Corient Private Wealth Portfolio holdings
Corient Private Wealth is the U.S. wealth management business that grew out of Canadian asset manager CI Financial's push into American wealth advisers. It was called CI Private Wealth until 2023, when it took the name Corient, a play on the words "client" and "oriented." Its advisers typically manage client portfolios by hiring and replacing outside investment managers and choosing individual securities, guided by an investment committee. Clients include individuals, among them high-net-worth individuals, as well as trusts, estates and charitable organizations.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$313M |
| 2 |
RTX Corp
RTX
|
+$247M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$246M |
| 4 |
Quanta Services
PWR
|
+$126M |
| 5 |
Marvell Technology
MRVL
|
+$94.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab International Equity ETF
SCHF
|
+$449M |
| 2 |
NVIDIA
NVDA
|
+$392M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$375M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$331M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$330M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 34.68% |
| 2 | Technology | 19.67% |
| 3 | Financials | 9.21% |
| 4 | Industrials | 7.58% |
| 5 | Healthcare | 7.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1426
Precigen
PGEN
$2.48B
| $1.9M | ﹤0.01% |
333,800
-577,406
| -63% | -$2.5M |
2024 Q3
7 quarters
|
|
1427
Embraer S.A. ADS
EMBJ
$13.1B
| $1.9M | ﹤0.01% |
29,778
-1,768
| -6% | -$109K |
2022 Q4
14 quarters
|
|
1428
CSW Industrials
CSW
$4.66B
| $1.9M | ﹤0.01% |
6,823
-705
| -9% | -$196K |
2023 Q4
10 quarters
|
|
1429
Lennox International
LII
$11.8B
| $1.9M | ﹤0.01% |
3,313
-41
| -1% | -$20.9K |
2022 Q4
14 quarters
|
|
1430
Vanguard Morningstar Mega Cap Value ETF
MGV
$14.1B
| $1.89M | ﹤0.01% |
11,589
-1,757
| -13% | -$273K |
2022 Q4
14 quarters
|
|
1431
Esquire Financial Holdings
ESQ
$1.52B
| $1.89M | ﹤0.01% |
15,838
-260
| -2% | -$28.8K |
2022 Q4
14 quarters
|
|
1432
EverQuote
EVER
$828M
| $1.88M | ﹤0.01% |
79,174
+36,461
| +85% | +$668K |
2026 Q1
1 quarter
|
|
1433
Stifel
SF
$10B
| $1.88M | ﹤0.01% |
26,950
-7,396
| -22% | -$551K |
2023 Q4
10 quarters
|
|
1434
DXC Technology
DXC
$2.39B
| $1.88M | ﹤0.01% |
211,960
-16,394
| -7% | -$170K |
2025 Q2
4 quarters
|
|
1435
Clear Secure
YOU
$4.73B
| $1.86M | ﹤0.01% |
33,390
+10,493
| +46% | +$574K |
2025 Q2
4 quarters
|
|
1436
iShares US Healthcare ETF
IYH
$4.62B
| $1.86M | ﹤0.01% |
27,762
+1,450
| +6% | +$90.7K |
2022 Q4
14 quarters
|
|
1437
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
$11.6B
| $1.85M | ﹤0.01% |
55,368
+47,038
| +565% | +$1.57M |
2022 Q4
14 quarters
|
|
1438
PBF Energy
PBF
$9.25B
| $1.85M | ﹤0.01% |
40,681
+27,142
| +200% | +$1.13M |
2022 Q4
14 quarters
|
|
1439
Blue Owl Capital
OWL
$7.06B
| $1.85M | ﹤0.01% |
211,631
+78,512
| +59% | +$746K |
2022 Q4
14 quarters
|
|
1440
Chewy
CHWY
$8.56B
| $1.85M | ﹤0.01% |
94,239
+4,183
| +5% | +$95K |
2025 Q4
2 quarters
|
|
1441
InterDigital
IDCC
$8.02B
| $1.85M | ﹤0.01% |
6,521
-31
| -0.5% | -$9.22K |
2022 Q4
14 quarters
|
|
1442
Northeast Bank
NBN
$1.07B
| $1.85M | ﹤0.01% |
13,927
+2,200
| +19% | +$272K |
2026 Q1
1 quarter
|
|
1443
CRISPR Therapeutics
CRSP
$4.97B
| $1.85M | ﹤0.01% |
33,841
-970
| -3% | -$51.1K |
2025 Q2
4 quarters
|
|
1444
Chicago Atlantic BDC
LIEN
$208M
| $1.85M | ﹤0.01% |
188,863
-191,885
| -50% | -$1.85M |
2025 Q2
4 quarters
|
|
1445
Napco Security Technologies
NSSC
$1.41B
| $1.84M | ﹤0.01% |
48,576
+37,186
| +326% | +$1.48M |
2025 Q3
3 quarters
|
|
1446
Covenant Logistics
CVLG
$785M
| $1.84M | ﹤0.01% |
41,743
-1,036
| -2% | -$37.8K |
2025 Q3
3 quarters
|
|
1447
Patriot National Bancorp
PNBK
$105M
| $1.84M | ﹤0.01% |
1,919,309
+440
| +0% | +$504 |
2025 Q3
3 quarters
|
|
1448
Armstrong World Industries
AWI
$6.96B
| $1.83M | ﹤0.01% |
11,393
-51,843
| -82% | -$8.47M |
2023 Q3
11 quarters
|
|
1449
Canadian Imperial Bank of Commerce
CM
$106B
| $1.82M | ﹤0.01% |
15,861
+307
| +2% | +$33.7K |
2023 Q1
13 quarters
|
|
1450
Arcus Biosciences
RCUS
$2.32B
| $1.82M | ﹤0.01% |
59,127
+34,984
| +145% | +$865K |
2025 Q2
4 quarters
|
|
Similar funds
Corient Private Wealth's Q2 2026 Portfolio in Review
As of Q2 2026, Corient Private Wealth held 3,273 positions worth $72.2B, up 3.4% from $69.9B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Corient Private Wealth withdrew a net $6.91B in Q2 2026, closing 231 positions and reducing 1,294 holdings. Its most notable exit was Masimo, an estimated $57.2M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, down from 37% a quarter earlier, followed by Technology and Financials.
Against the trend, Corient Private Wealth opened a new position in Powerlaw Corp worth $56.7M.
- Corient Private Wealth's largest Q2 2026 buy was Powerlaw Corp: 3,862,217 shares worth $56.7M.
- Corient Private Wealth added most to Invesco QQQ Trust in Q2 2026, an estimated $313M increase.
- Corient Private Wealth's biggest Q2 2026 reduction was Schwab International Equity ETF, cutting an estimated $449M.
- Corient Private Wealth fully exited Masimo in Q2 2026, selling an estimated $57.2M.
- Corient Private Wealth's ten largest holdings make up 27% of its $72.2B portfolio in Q2 2026.
- Corient Private Wealth opened 439 new positions and closed 231 in Q2 2026.
- Corient Private Wealth's portfolio value rose 3.4% quarter-over-quarter to $72.2B.
Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.